224 related articles for article (PubMed ID: 31860417)
1. Extramammary Paget's disease: what do we know and how do we treat?
Adashek JJ; Leonard A; Nealon SW; Krishnan A; Mosiello GC; Dhillon J; Spiess PE
Can J Urol; 2019 Dec; 26(6):10012-10021. PubMed ID: 31860417
[TBL] [Abstract][Full Text] [Related]
2. Extramammary Paget's Disease: Diagnosis, Pathogenesis, and Treatment with Focus on Recent Developments.
Ishizuki S; Nakamura Y
Curr Oncol; 2021 Aug; 28(4):2969-2986. PubMed ID: 34436026
[TBL] [Abstract][Full Text] [Related]
3. Extramammary Paget's Disease.
Asel M; LeBoeuf NR
Hematol Oncol Clin North Am; 2019 Feb; 33(1):73-85. PubMed ID: 30497678
[TBL] [Abstract][Full Text] [Related]
4. Serum cytokeratin 19 fragment 21-1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary Paget disease.
Nakamura Y; Tanese K; Hirai I; Amagai M; Kawakami Y; Funakoshi T
Br J Dermatol; 2019 Sep; 181(3):535-543. PubMed ID: 30791097
[TBL] [Abstract][Full Text] [Related]
5. Extramammary Paget's disease: an annotated review.
Balducci L; Crawford ED; Smith GF; Lambuth B; McGehee R; Hardy C
Cancer Invest; 1988; 6(3):293-303. PubMed ID: 2844363
[TBL] [Abstract][Full Text] [Related]
6. The diagnosis and management of extramammary Paget's disease.
Ito T; Kaku-Ito Y; Furue M
Expert Rev Anticancer Ther; 2018 Jun; 18(6):543-553. PubMed ID: 29575944
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget's disease.
Mai R; Zhou S; Zhou S; Zhong W; Hong L; Wang Y; Lu S; Pan J; Huang Y; Su M; Crawford R; Zhou Y; Zhang G
Hum Pathol; 2018 Jul; 77():152-158. PubMed ID: 29630912
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients.
Kang Z; Zhang Q; Zhang Q; Li X; Hu T; Xu X; Wu Z; Zhang X; Wang H; Xu J; Xu F; Guan M
Int J Clin Exp Pathol; 2015; 8(10):13233-40. PubMed ID: 26722523
[TBL] [Abstract][Full Text] [Related]
9. Extramammary Paget's disease of the scrotum associated with hepatocellular carcinoma.
Li YC; Lu LY; Yang YT; Chang CC; Chen LM
J Chin Med Assoc; 2009 Oct; 72(10):542-6. PubMed ID: 19837650
[TBL] [Abstract][Full Text] [Related]
10. MiR-155, a potential serum marker of extramammary Paget's disease.
Guo H; Qi RQ; Sheng J; Liu C; Ma H; Wang HX; Li JH; Gao XH; Wan YS; Chen HD
BMC Cancer; 2018 Nov; 18(1):1078. PubMed ID: 30458743
[TBL] [Abstract][Full Text] [Related]
11. Extramammary Paget's disease: Summary of current knowledge.
Lam C; Funaro D
Dermatol Clin; 2010 Oct; 28(4):807-26. PubMed ID: 20883922
[TBL] [Abstract][Full Text] [Related]
12. KS-EMPD-1: a novel cell line of primary extramammary Paget's disease.
Ito T; Tanaka Y; Ichiki T; Kaku-Ito Y; Nakahara T
Hum Cell; 2023 Sep; 36(5):1813-1829. PubMed ID: 37432591
[TBL] [Abstract][Full Text] [Related]
13. Mammary and Extramammary Paget's Disease Presented Different Expression Pattern of Steroid Hormone Receptors.
Zhou S; Zhong W; Mai R; Zhang G
Biomed Res Int; 2017; 2017():3768247. PubMed ID: 29082243
[TBL] [Abstract][Full Text] [Related]
14. A review of non-invasive imaging in extramammary Paget's disease.
Bayan CY; Khanna T; Rotemberg V; Samie FH; Zeitouni NC
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1862-1873. PubMed ID: 29763511
[TBL] [Abstract][Full Text] [Related]
15. Extramammary Paget's Disease: A Review of the Literature Part II: Treatment and Prognosis.
Morris CR; Hurst EA
Dermatol Surg; 2020 Mar; 46(3):305-311. PubMed ID: 31688232
[TBL] [Abstract][Full Text] [Related]
16. Prognosis and management of extramammary Paget's disease and the association with secondary malignancies.
Pierie JP; Choudry U; Muzikansky A; Finkelstein DM; Ott MJ
J Am Coll Surg; 2003 Jan; 196(1):45-50. PubMed ID: 12517548
[TBL] [Abstract][Full Text] [Related]
17. Extramammary Paget Disease: A Review of the Literature-Part I: History, Epidemiology, Pathogenesis, Presentation, Histopathology, and Diagnostic Work-up.
Morris CR; Hurst EA
Dermatol Surg; 2020 Feb; 46(2):151-158. PubMed ID: 31356440
[TBL] [Abstract][Full Text] [Related]
18. miR-31 is distinctively overexpressed in primary male extramammary Paget's disease.
Guo H; Qi RQ; Lv YN; Wang HX; Hong YX; Zheng S; Li JH; Gao XH; Chen HD
Oncotarget; 2016 Apr; 7(17):24559-63. PubMed ID: 27016415
[TBL] [Abstract][Full Text] [Related]
19. Serum cell-free DNA levels are a useful marker for extramammary Paget disease.
Mijiddorj T; Kajihara I; Tasaki Y; Otsuka-Maeda S; Sakamoto R; Sawamura S; Kanazawa-Yamada S; Egashira S; Inoue K; Makino K; Miyashita A; Aoi J; Igata T; Makino T; Masuguchi S; Fukushima S; Jinnin M; Morinaga J; Ikeda T; Ihn H
Br J Dermatol; 2019 Sep; 181(3):505-511. PubMed ID: 30706452
[TBL] [Abstract][Full Text] [Related]
20. Role of androgen signaling in androgen receptor-positive extramammary Paget's disease: Establishment of organoids and their biological analysis as a novel therapeutic target.
Nakamura Y; Mizukami H; Tanese K; Fusumae T; Hirai I; Amagai M; Takamatsu R; Nakamura K; Nishihara H; Takimoto T; Ueno M; Saya H; Funakoshi T
J Dermatol Sci; 2023 Oct; 112(1):23-30. PubMed ID: 37661472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
